J. Saranya

Dr. J. Saranya

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 February 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
JSJ. Saranya
J. Saranya
PSP. Saminathan
P. Saminathan
SASeshadri Reddy Ankireddy
Seshadri Reddy Ankireddy
Mohammed Rafi ShaikMohammed Rafi Shaik
Mohammed Rafi Shaik
Mujeeb KhanMujeeb Khan
Mujeeb Khan
BSBAJI SHAIK
BAJI SHAIK
In the present study, we used a simple ultrasonic approach to develop a Cerium oxide/Graphene oxide hybrid (CeO2/GO hybrid) nanocomposite system. Particle size analysis, Fourier Transform Infrared Spectroscopy (FTIR), Scanning Electron Microscopy (SEM), and X-ray Diffraction (XRD) have been used to analyze the physio-chemical characteristics of the developed nanocomposite. The synthesized hybrid system has also been examined to assess its anticancer capability against MCF-7 cell lines and normal cell lines at different sample concentrations, pH values, and incubation intervals using an antiproliferative assay test. The test results demonstrate that as sample concentration rises, the apoptotic behavior of the CeO2/GO hybrid in the MCF-7 cell line also rises. The IC50 was 62.5 µg/mL after 72 h of incubation. Cytotoxicity of cisplatin bound CeO2/GO hybrid was also tested in MCF-7 cell lines. To identify apoptosis-associated alterations of cell membranes during the process of apoptosis, a dual acridine orange/ethidium bromide (AO/EB) fluorescence staining was carried out at three specified doses (i.e., 1000 µg/mL, 250 µg/mL, and 62.5 µg/mL of CeO2/GO hybrid). The color variations from both live (green) and dead (red) cells were examined using fluorescence microscopy under in vitro conditions. The quantitative analysis was performed using flow cytometry to identify the cell cycle at which the maximum number of MCF-7 cells had been destroyed as a result of interaction with the developed CeO2/GO hybrid (FACS study). According to the results of the FACS investigation, the majority of cancer cells were inhibited at the R3 (G2/M) phase. Therefore, the CeO2/GO hybrid has successfully showed enhanced anticancer efficacy against the MCF-7 cell line at the IC50 concentration. According to the current study, the CeO2/GO platform can be used as a therapeutic platform for breast cancer. The synergetic effects of the developed CeO2/GO hybrid with the MCF-7 cell line are presented.

19 September 2023 in Crystals
Verified
Journal Article
Open access
PDF file
JSJ. Saranya
J. Saranya
SPS. Preethi
S. Preethi
Mohammed Rafi ShaikMohammed Rafi Shaik
Mohammed Rafi Shaik
Merajuddin  KhanMerajuddin Khan
Merajuddin Khan
Mujeeb KhanMujeeb Khan
Mujeeb Khan
BSBAJI SHAIK
BAJI SHAIK
A ternary nanocomposite was prepared using cerium oxide, chitosan, and graphene oxide (CeO2/CS/GO) using a simple and cost-effective wet chemical method. The physicochemical properties of the developed ternary nanocomposite were examined using X-ray diffraction, Fourier transform infrared spectroscopy, scanning electron microscopy with energy-dispersive X-ray spectroscopy, and ultraviolet-visible spectroscopy. Furthermore, the therapeutic behavior of the developed CeO2/CS/GO composite was assessed using anti-bacterial, anti-fungal, and anti-cancer assays. For Escherichia coli, Staphylococcus aureus, and Salmonella species, 750 µg/mL of the CeO2/CS/GO composite showed effective anti-bacterial activity, with a zone of inhibition of 9 mm. Additionally, the CeO2/CS/GO composite’s anti-fungal activity against Aspergillus niger was studied. The anti-cancer properties of different concentrations of the CeO2/CS/GO composite were assessed on MCF-7 cells, and 18.8% of cells were found to be viable at the maximum concentration of 1000 µg/mL CeO2/CS/GO and 46.37% at 125 µg/mL. The results of the hemolysis assay performed using human red blood cells and various concentrations of the CeO2/CS/GO composite indicated that the nanocomposite possesses biological properties. Overall, it can act as a therapeutic platform for breast cancer, bacterial and fungal infections.

28 February 2025
Verified
Book Chapter
Closed access
JSJ. Saranya
J. Saranya
MAM. Anithamary
M. Anithamary
KMK. Murugesh
K. Murugesh
KDK. Dinesh
K. Dinesh
The healthcare industry is in a “state of emergency” as a result of recent catastrophic events that have disrupted the ongoing delivery of service in healthcare sector. The combined effects of increased cost of living and an aging population are making life miserable for the common people. Very Large Scale Integration (VLSI) technology is important for biomedical applications because it allows biomedical devices to be more functional, smaller, and perform better due to its potential to combine a large number of transistors onto a single chip. They make it possible for fast data processing and ability to perform reconstruction raises the standard in the precision of diagnosis. Real-time transmission of patient data to healthcare practitioners through these systems allows for prompt treatments and decreases the number of hospital visits.This chapter elaborates on approaches that includes reduction in switching capacitance and supply voltage in the design and implementation of low-power, low-voltage VLSI circuit designs.

4 May 2023 in Applied Nanoscience
Verified
Journal Article
Closed access
PDF file
JSJ. Saranya
J. Saranya
BSB. S. Sreeja
B. S. Sreeja
PKP. Senthil Kumar
P. Senthil Kumar

1 January 2023 in AIP Conference Proceedings
Verified
Conference Paper
Open access
PDF file
SPSheena Pravin
Sheena Pravin
SKSindhu Kanagasabapathy
Sindhu Kanagasabapathy
VSVishalbalaji Sivaraman
Vishalbalaji Sivaraman
JSJ. Saranya
J. Saranya
PMPalanivelan Manickavelu
Palanivelan Manickavelu
Diabetic Retinopathy is ubiquitous amongst a huge demographic section with acute diabetes. It is a perilous disease which may induce injury in the retinal tissues for subjects with diabetes. Prolonged Diabetic Retinopathy may lead to permanent blindness. Therefore, it is essential to spot Diabetic Retinopathy at an initial stage to prevent its severity. Several models were proposed earlier to detect Diabetic Retinopathy using deep learning models combined with image analysis. In this research work, the CNN based Efficient CNN pre-trained deep learning model was utilized to hasten the intensity level detection of Diabetic Retinopathy. The model learnt features from the retinal images. The images belong to five unique classes, that define the intensity of DR. Efficient CNN, a deep learning model is proposed for Diabetic Retinopathy intensity detection. The Efficient CNN has shown to achieve a classification accuracy of 0.94 on the test set and 0.99 on the training set. The model has been validated using classification accuracy, Quadratic Weighted Kappa score, Jaccard Similarity Index and F1-score. An optimal accuracy was obtained over the model. Thus, the implemented model may help the patients with Diabetic Retinopathy, from complete blindness.

20 July 2022
Verified
Book Chapter
Closed access
PDF file
SPSheena Christabel Pravin
Sheena Christabel Pravin
JSJ. Saranya
J. Saranya
SSSuganthi Selvakumar
Suganthi Selvakumar
VSV. S. Selvakumar
V. S. Selvakumar
BJBeulah Jackson
Beulah Jackson
SVS. Visalaxi
S. Visalaxi